We are live on ! Find out more
ECM

Elgethun Capital Management Portfolio holdings

AUM $718M
1-Year Est. Return 18.6%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+18.6%
3 Year Est. Return
+61.47%
5 Year Est. Return
+71.42%
10 Year Est. Return
AUM
$397M
AUM Growth
+$43.4M
Cap. Flow
+$17.7M
Cap. Flow %
4.47%
Top 10 Hldgs %
46.7%
Holding
157
New
3
Increased
70
Reduced
33
Closed
1

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$8.27M
2
LBTYK icon
Liberty Global Class C
LBTYK
+$3.06M
3
BOC icon
Boston Omaha
BOC
+$2.01M
4
GLD icon
SPDR Gold Trust
GLD
+$678K
5
MRK icon
Merck
MRK
+$644K

Sector Composition

Rank Sector Weight
1 Financials 33.57%
2 Consumer Discretionary 8.7%
3 Healthcare 8.12%
4 Communication Services 6.3%
5 Technology 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
26
Citigroup
C
$226B
$4.31M 1.09%
67,867
+8,197
+14% +$456K
AXP icon
27
American Express
AXP
$230B
$4.14M 1.04%
18,143
+252
+1% +$52.3K
DFH icon
28
Dream Finders Homes
DFH
$1.36B
$4M 1.01%
92,628
-4,203
-4% -$148K
ACI icon
29
Albertsons Companies
ACI
$5.83B
$3.99M 1.01%
187,747
-320
-0.2% -$6.86K
SBUX icon
30
Starbucks
SBUX
$120B
$3.95M 1%
43,074
+1,075
+3% +$100K
UNH icon
31
UnitedHealth
UNH
$370B
$3.76M 0.95%
7,631
-195
-2% -$99.1K
JNJ icon
32
Johnson & Johnson
JNJ
$625B
$3.51M 0.89%
22,387
+2,487
+12% +$396K
BUD icon
33
AB InBev
BUD
$165B
$3.46M 0.87%
56,931
+1,444
+3% +$90.4K
AMZN icon
34
Amazon
AMZN
$2.96T
$3.18M 0.8%
17,605
CVS icon
35
CVS Health
CVS
$122B
$3.02M 0.76%
38,017
-204
-0.5% -$15.6K
IWR icon
36
iShares Russell Mid-Cap ETF
IWR
$57.4B
$2.98M 0.75%
35,550
+8
+0% +$634
AAPL icon
37
Apple
AAPL
$4.57T
$2.79M 0.7%
16,349
-58
-0.4% -$10.5K
EPD icon
38
Enterprise Products Partners
EPD
$81.7B
$2.77M 0.7%
94,547
+5,188
+6% +$142K
SCHX icon
39
Schwab US Large- Cap ETF
SCHX
$74.5B
$2.55M 0.64%
122,862
-2,145
-2% -$42.2K
WBD icon
40
Warner Bros
WBD
$67.1B
$2.48M 0.63%
284,388
-881
-0.3% -$8.49K
VBR icon
41
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
$2.29M 0.58%
11,994
+1,755
+17% +$317K
OPFI icon
42
OppFi
OPFI
$803M
$1.7M 0.43%
678,393
-12,422
-2% -$42.2K
KVUE icon
43
Kenvue
KVUE
$36.9B
$1.63M 0.41%
76,879
-840
-1% -$17.1K
MRK icon
44
Merck
MRK
$318B
$1.59M 0.4%
12,210
+5,224
+75% +$644K
SCHV
45
Schwab US Large-Cap Value ETF
SCHV
$16.1B
$1.49M 0.38%
59,061
+1,257
+2% +$30.1K
WRB icon
46
W.R. Berkley
WRB
$26.6B
$1.41M 0.36%
24,057
+3
+0% +$162
WMT icon
47
Walmart Inc
WMT
$890B
$1.39M 0.35%
22,945
+2,938
+15% +$168K
GOOG icon
48
Alphabet (Google) Class C
GOOG
$4.32T
$1.32M 0.33%
8,420
-40
-0.5% -$5.77K
ABBV icon
49
AbbVie
ABBV
$435B
$1.3M 0.33%
7,245
+20
+0.3% +$3.45K
BWB icon
50
Bridgewater Bancshares
BWB
$603M
$1.28M 0.32%
110,735
-3,665
-3% -$44.7K

Similar funds

Elgethun Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Elgethun Capital Management held 157 positions worth $397M, up 12% from $353M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Elgethun Capital Management deployed $17.7M of net new capital in Q1 2024, opening 3 new positions and adding to 70 existing holdings. Its largest new stake was SPDR Gold Trust: 3,531 shares worth $732K.

By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $512K trimmed.

  • Elgethun Capital Management's largest Q1 2024 buy was SPDR Gold Trust: 3,531 shares worth $732K.
  • Elgethun Capital Management added most to Eli Lilly in Q1 2024, an estimated $8.27M increase.
  • Elgethun Capital Management's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $512K.
  • Elgethun Capital Management fully exited SAB Biotherapeutics in Q1 2024, selling an estimated $6.47K.
  • Elgethun Capital Management's ten largest holdings make up 47% of its $397M portfolio in Q1 2024.
  • Elgethun Capital Management opened 3 new positions and closed 1 in Q1 2024.
  • Elgethun Capital Management's portfolio value rose 12% quarter-over-quarter to $397M.

Based on Elgethun Capital Management's 13F filing for Q1 2024, filed 14 May 2024.